269 related articles for article (PubMed ID: 31624635)
1. The hubris and humility of cancer pharmacology in the post immuno-oncology era.
Lazo JS
Pharmacol Res Perspect; 2019 Dec; 7(6):e00527. PubMed ID: 31624635
[TBL] [Abstract][Full Text] [Related]
2. Immuno-oncology for surgeons.
Lee SL; Al-Shamkhani A; Mirnezami A
Br J Surg; 2019 Sep; 106(10):1273-1282. PubMed ID: 31318438
[TBL] [Abstract][Full Text] [Related]
3.
Ngo N; Choucair K; Creeden JF; Qaqish H; Bhavsar K; Murphy C; Lian K; Albrethsen MT; Stanbery L; Phinney RC; Brunicardi FC; Dworkin L; Nemunaitis J
Future Oncol; 2019 Nov; 15(33):3861-3876. PubMed ID: 31668087
[TBL] [Abstract][Full Text] [Related]
4. Evolving Paradigms of Personalized Medicine in Oncology.
Dhingra K
Natl Med J India; 2017; 30(6):305-308. PubMed ID: 30117439
[No Abstract] [Full Text] [Related]
5. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Mooradian MJ; Sullivan RJ
Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
[TBL] [Abstract][Full Text] [Related]
7. Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials.
Paliard X; Rixe O
Target Oncol; 2019 Dec; 14(6):631-637. PubMed ID: 31595386
[TBL] [Abstract][Full Text] [Related]
8. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
9. Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types.
van den Ende T; van den Boorn HG; Hoonhout NM; van Etten-Jamaludin FS; Meijer SL; Derks S; de Gruijl TD; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188386. PubMed ID: 32540465
[TBL] [Abstract][Full Text] [Related]
10. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
11. Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance.
Owyong M; Hosseini-Nassab N; Efe G; Honkala A; van den Bijgaart RJE; Plaks V; Smith BR
Drug Resist Updat; 2017 Nov; 33-35():23-35. PubMed ID: 29145972
[TBL] [Abstract][Full Text] [Related]
12. Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit.
Kato S; Subbiah V; Kurzrock R
J Natl Compr Canc Netw; 2017 Jul; 15(7):863-866. PubMed ID: 28687573
[No Abstract] [Full Text] [Related]
13. The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy.
Ferreira CG; Nicolini A; Dalurzo L; Stefani S; Teich V; Leighl N
Curr Drug Targets; 2019; 20(1):81-86. PubMed ID: 30207218
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology.
Peskov K; Azarov I; Chu L; Voronova V; Kosinsky Y; Helmlinger G
Front Immunol; 2019; 10():924. PubMed ID: 31134058
[TBL] [Abstract][Full Text] [Related]
15. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
16. Immuno-Oncology in China.
Lu S; Chabner BA
Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825
[TBL] [Abstract][Full Text] [Related]
17. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
Golan T; Milella M; Ackerstein A; Berger R
J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
[TBL] [Abstract][Full Text] [Related]
18. Integrative Pharmacology: Advancing Development of Effective Immunotherapies.
Tabrizi M; Zhang D; Ganti V; Azadi G
AAPS J; 2018 Apr; 20(4):66. PubMed ID: 29704129
[TBL] [Abstract][Full Text] [Related]
19. Turning tumors from cold to inflamed to improve immunotherapy response.
Gerard CL; Delyon J; Wicky A; Homicsko K; Cuendet MA; Michielin O
Cancer Treat Rev; 2021 Dec; 101():102227. PubMed ID: 34656019
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy: Current applications and challenges.
Sun JY; Lu XJ
Cancer Lett; 2020 Jun; 480():1-3. PubMed ID: 32229188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
